eMedicine Specialties > Urology > Hydronephrosis and Ureter Disorders

Ureteropelvic Junction Obstruction

Author: Michael Grasso, MD, Chairman, Department of Urology, Saint Vincent's Medical Center; Professor and Vice Chairman, Department of Urology, New York Medical College
Coauthor(s): Srinivas Rajamahanty, MD, MCh, Staff Physician, Department of Urology, Westchester Medical Center, Valhalla, New York; Jordan S Gitlin, MD, Assistant Professor, Department of Urology, Albert Einstein College of Medicine-Yeshiva University; Consulting Staff, Pediatric Urology Associates PC; G Blake Johnson, MD, Consulting Staff, Middleton Urology Associates
Contributor Information and Disclosures

Updated: Mar 30, 2009

Introduction

Ureteropelvic junction (UPJ) obstruction is defined as an obstruction of the flow of urine from the renal pelvis to the proximal ureter. The condition is frequently encountered by both adult and pediatric urologists. Congenital abnormalities may be observed in both adults and children, but adults may also present with UPJ obstruction following previous surgery or other disorders that can cause inflammation of the upper urinary tract.

The critical decision to be made in dealing with suspected UPJ obstruction is whether the radiologic findings correlate with the physiologic picture. In other words, severely dilated hydronephrotic kidneys may, in fact, drain well when studied appropriately. Defining the exact anatomy and function of these kidneys is crucial when evaluating and treating these patients.

The treatment strategies for UPJ obstruction have seen a significant shift in the last several years. The gamut of surgical treatments for UPJ obstruction today include laparoscopic pyeloplasty, open pyeloplasty, endopyelotomy, endopyeloplasty, and robotic-assisted laparoscopic pyeloplasty.

While open pyeloplasty is still considered the criterion standard for UPJ obstruction in infants, laparoscopic pyeloplasty, with or without robotic assistance, is the treatment of choice in older children and in most adults.1

History of the Procedure

UPJ obstruction is the most common cause of neonatal and antenatal hydronephrosis, occurring in 1 per 1500 live births. Prior to the use of prenatal ultrasonography, most patients with UPJ obstruction presented with pain, hematuria, urosepsis, failure to thrive, or a palpable mass. With the enhanced ability and availability of prenatal ultrasonography, urologic abnormalities are being diagnosed earlier and more frequently. Fifty percent of patients diagnosed with antenatal hydronephrosis are eventually diagnosed with UPJ obstruction upon further workup.

Initially, most children are treated conservatively and monitored closely. Intervention is indicated in the event of significantly impaired renal drainage or poor renal growth.

Problem

UPJ obstruction is defined as an obstruction of the flow of urine from the renal pelvis to the proximal ureter. The resultant back pressure within the renal pelvis may lead to progressive renal damage and deterioration.

UPJ obstruction presents most frequently in childhood, but adults and elderly individuals can also present with a primary obstructive lesion. In adults, other etiologies for ureteral obstruction must be considered, including stones, ureteral compression due to extrinsic processes, retroperitoneal fibrosis, and other inflammatory processes.

Frequency

  • Ultrasonography reveals fetal upper urinary tract dilatation in approximately 1 in 100 pregnancies. However, only 1 in 500 are later diagnosed with significant urologic problems.
  • UPJ obstruction is found in approximately 50% of patients diagnosed with antenatal hydronephrosis.
  • The male-to-female ratio of UPJ obstruction is 3-4:1.
  • In general, the left kidney is more commonly affected than the right kidney.
  • UPJ obstruction is less common in adults than in children but is not rare in either population.

Etiology

Possible etiologies for UPJ obstruction include the following:

  • Intrinsic obstruction may result from stenosis due to scarring of ureteral valves.
  • Ureteral hypoplasia may result in abnormal peristalsis through the UPJ. Asymmetry of ureteral wall musculature may inhibit the natural peristaltic emptying of the renal pelvis into the ureter.
  • An abnormal or high insertion of the ureter into the renal pelvis may alter the configuration and impair drainage of urine. This may be an effect rather than a cause because the two etiologies mentioned above may manifest as a high-insertion variant seen on imaging studies.
  • Crossing lower-pole renal vessel(s) or entrapment of the ureter by a vessel can prohibit urinary flow down the ureter. Vessels that wrap around the UPJ may be associated with obstruction or may be a product of renal dilatation and hydronephrosis that distorts renal vascular architecture.
  • Rotation of the kidney (eg, renal ectopy) and renal hypermobility can cause intermittent obstruction that is solely dependent on the position of the kidney relative to the ureter. This was once a very popular diagnosis; however, the other etiologies mentioned above are more prevalent today, and this cause is particularly rare.
  • Secondary UPJ obstruction can be caused by prior surgical intervention to treat other disorders (eg, renal stone disease) or failed repair of a primary UPJ obstruction. This obstructive lesion is usually secondary to ureteral-wall and periureteral scar formation.
  • UPJ obstruction manifests bilaterally in 10% cases.

All of the above abnormalities impair drainage of urine from the kidney into the ureter, resulting in elevated intrarenal back pressure, dilatation of the collecting system, and hydronephrosis.

Recent scanning electron microscopy studies using 3-dimensional techniques have shown that normal elasticity and distension of the renal pelvis are impaired secondary to rigid collagen bundling. Increased collagen deposition between smooth muscle cells result in wider cell-to-cell and nerve-to-cell distances. Neural depletion has also been reported. In addition, immunohistochemical studies have shown decreased neuronal markers and nerve growth factors within the smooth muscle layer, thus impeding peristalsis.

Studies are ongoing to search for reliable biomarkers for UPJ obstruction. Epidermal growth factor (EGF), transforming growth factor-beta-1 (TGF-beta-1), and angiotensin 11 are some of the substances under investigation. In the rat model, acute obstruction resulted in increased levels of angiotensin 11 and increased TGF-beta expression, resulting in pathological deposition of extracellular matrix, which may be one mechanism that leads to obstruction.

Presentation

Neonates who present with hydronephrosis should be fully evaluated with voiding cystourethrography (VCUG; to rule out vesicoureteral reflux) and renal ultrasonography soon after birth. These patients should also be placed on prophylactic antibiotics (amoxicillin 15 mg/kg) to prevent urinary tract infections (UTIs), especially while diagnostic imaging is being performed. If renal ultrasonography demonstrates hydronephrosis without reflux on VCUG, a diuretic renal scan (mercaptotriglycylglycine [MAG-3], diethylenetriamine [DTPA], or dimercaptosuccinic acid [DMSA]) should be performed to quantify relative renal function and to define the extent of obstruction.

Older children may present with UTI, a flank mass, or intermittent flank pain secondary to a primary UPJ obstruction. Hematuria may also be a presenting sign if it is associated with infection.

Adults with UPJ obstruction can present with various symptoms, including back and flank pain, UTI, and/or pyelonephritis. A detailed history may reveal that the pain correlates with periods of increased fluid intake or ingestion of a food with diuretic properties (ie, Dietl crisis).

Indications

The goals in treating patients with ureteropelvic junction (UPJ) obstruction are to improve renal drainage and to maintain or improve renal function.

As mentioned above, dilatation of the intrarenal collecting system or hydronephrosis does not necessarily imply obstruction. Specifically in children, renal pelvic dilatation should be monitored with serial imaging to assess for changes in dilatation, renal parenchymal thickness and/or the presence of scarring, and function. Surgical repair is indicated upon a significant differential on serial imaging or progressive deterioration of renal function.

Using this algorithm, patients with hydronephrosis are monitored closely with renal ultrasonography and nuclear medicine renography every 3-6 months. Similarly, in adults, repair is recommended if nuclear medicine renal scan or intravenous pyelography (IVP) reveals ureteral obstruction.

Relevant Anatomy

The evaluation of an obstructed ureteropelvic junction (UPJ) requires information about ureteral and surrounding anatomy, renal position and ectopy, associated vasculature, and renal function. Prior to surgical intervention, the surgeon frequently evaluates for renal position/ectopy, mobility, and UPJ anatomy, such as high-insertion variants versus annular stricture variants.

The major vascular supply of the UPJ comes from branches of the renal artery. These vessels usually lie in an anteromedial location in relation to the proximal ureter. Aberrant polar vessels may also be associated with the renal pelvis, causing compression and obstruction of the collecting system (see Image 7). These vessels arise from either the renal artery from a position proximal to the main intrarenal branching site or directly from the aorta. They can surround the UPJ and can be associated with obstruction, or they may be aberrantly positioned secondary to increasing hydronephrosis.

Intraluminal sonogram demonstrating the renal vei...

Intraluminal sonogram demonstrating the renal vein surrounding the ureteropelvic junction and causing extrinsic compression and obstruction.

Intraluminal sonogram demonstrating the renal vei...

Intraluminal sonogram demonstrating the renal vein surrounding the ureteropelvic junction and causing extrinsic compression and obstruction.


An endopyelotomy refers to an endoscopic incision of the UPJ, performed to create a more funneled drainage system and to bring the UPJ more dependent or caudad below areas of pathology.

The vascular anatomy at the UPJ becomes crucial during an endopyelotomy. The renal collecting system may be accessed percutaneously (antegrade) or in a retrograde fashion via passage of a ureteroscope through the urethra, bladder, and ureter in order to access the obstruction and to perform an incision. While most associated UPJ vessels lie in the anteromedial plane, accessory vessels may lie posteriorly or laterally. If all endoscopic incisions are made in the posterior-lateral plane, intraoperative hemorrhage may occur. For this reason, a comprehensive vascular evaluation with intraoperative endoluminal ultrasonography, preoperative CT scanning, or MRI with vascular reconstruction is recommended prior to this form of treatment (see Images 5 and 6).

CT scan without contrast demonstrating severe lef...

CT scan without contrast demonstrating severe left-sided hydronephrosis secondary to ureteropelvic junction obstruction.

CT scan without contrast demonstrating severe lef...

CT scan without contrast demonstrating severe left-sided hydronephrosis secondary to ureteropelvic junction obstruction.


CT scan with intravenous contrast demonstrating p...

CT scan with intravenous contrast demonstrating pooling of contrast and delayed excretion of contrast from a left-sided ureteropelvic junction obstruction (see Image 3 for retrograde pyelogram in this patient).

CT scan with intravenous contrast demonstrating p...

CT scan with intravenous contrast demonstrating pooling of contrast and delayed excretion of contrast from a left-sided ureteropelvic junction obstruction (see Image 3 for retrograde pyelogram in this patient).


Multidetector CT scanning with 3-dimensional reconstruction can be particularly helpful in establishing the anatomy of UPJ obstruction, revealing an intrinsic or high-insertion UPJ. Crossing vessels and their relationship to the ureter of the UPJ can also be evaluated. The location of these vessels and their possible contribution to renal obstruction can help the surgeon clinically decide whether endopyelotomy, open pyeloplasty, or laparoscopic pyeloplasty would be the most effective treatment modality.

When an open or laparoscopic pyeloplasty is performed, an accurate understanding of the vascular anatomy allows the surgeon to preserve the accessory renal vessels and to redirect them if the surgeon feels that they contribute to the obstruction. If an endopyelotomy is planned, this information can guide the surgeon in directing the endopyelotomy incision away from crossing vessels. CT scanning in combination with 3-phase and 3-dimensional contrast imaging yields a reported sensitivity of 75%-97% in revealing crossing vessels. El-Nahas et al reported that CT scanning yielded a sensitivity of 97%, specificity of 92%, and accuracy of 96% in detecting crossing vessels associated with UPJ obstruction.2

Retrograde pyelography at the time of surgery is often used to estimate the length of the stricture and the amount of pelvis/ureter that needs to be excised at the time of the pyeloplasty to create a dependent funnel.

More on Ureteropelvic Junction Obstruction

Overview: Ureteropelvic Junction Obstruction
Workup: Ureteropelvic Junction Obstruction
Treatment: Ureteropelvic Junction Obstruction
Follow-up: Ureteropelvic Junction Obstruction
Multimedia: Ureteropelvic Junction Obstruction
References

References

  1. Symons SJ, Bhirud PS, Jain V, Shetty AS, Desai MR. Laparoscopic pyeloplasty: our new gold standard. J Endourol. Mar 2009;23(3):463-7. [Medline].

  2. El-Nahas AR, Abou-El-Ghar M, Shoma AM, Eraky I, El-Kenawy MR, El-Kappany H. Role of multiphasic helical computed tomography in planning surgical treatment for pelvi-ureteric junction obstruction. BJU Int. Sep 2004;94(4):582-7. [Medline].

  3. Kim S, Jacob JS, Kim DC, Rivera R, Lim RP, Lee VS. Time-resolved dynamic contrast-enhanced MR urography for the evaluation of ureteral peristalsis: initial experience. J Magn Reson Imaging. Nov 2008;28(5):1293-8. [Medline].

  4. Gill IS, Desai MM, Kaouk JH, Wani K, Desai MR. Percutaneous endopyeloplasty: description of new technique. J Urol. Nov 2002;168(5):2097-102. [Medline].

  5. Shapiro EY, Cho JS, Srinivasan A, Seideman CA, Huckabay CP, Andonian S, et al. Long-term follow-up for salvage laparoscopic pyeloplasty after failed open pyeloplasty. Urology. Jan 2009;73(1):115-8. [Medline].

  6. Casale P. Robotic pyeloplasty in the pediatric population. Curr Urol Rep. Jan 2009;10(1):55-9. [Medline].

  7. Bagley DH, Liu JB. Endoureteral sonography to define the anatomy of the obstructed ureteropelvic junction. Urol Clin North Am. May 1998;25(2):271-9. [Medline].

  8. Baniel J, Livne PM, Savir A. Dismembered pyeloplasty in children with and without stents. Eur Urol. 1996;30(3):400-2. [Medline].

  9. Boylu U, Oommen M, Lee BR, Thomas R. Ureteropelvic junction obstruction secondary to crossing vessels-to transpose or not? The robotic experience. J Urol. Apr 2009;181(4):1751-5. [Medline].

  10. Casale P, Grady RW, Joyner BD, Zeltser IS, Figueroa TE, Mitchell ME. Comparison of dismembered and nondismembered laparoscopic pyeloplasty in the pediatric patient. J Endourol. Nov 2004;18(9):875-8. [Medline].

  11. Chow GK, Geisinger MA, Streem SB. Endopyelotomy outcome as a function of high versus dependent ureteral insertion. Urology. Dec 1999;54(6):999-1002. [Medline].

  12. Conway JJ, Maizels M. The "well tempered" diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. A report from combined meetings of The Society for Fetal Urology and members of The Pediatric Nuclear Medicine C. J Nucl Med. Nov 1992;33(11):2047-51. [Medline].

  13. el-Nahas AR, Shoma AM, Eraky I, el-Kenawy MR, el-Kappany HA. Prospective, randomized comparison of ureteroscopic endopyelotomy using holmium:YAG laser and balloon catheter. J Urol. Feb 2006;175(2):614-8; discussion 618. [Medline].

  14. El-Sherbiny MT, Mousa OM, Shokeir AA, Ghoneim MA. Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in children. J Urol. Oct 2002;168(4 Pt 2):1798-800. [Medline].

  15. Figenshau RS, Clayman RV. Endourologic options for management of ureteropelvic junction obstruction in the pediatric patient. Urol Clin North Am. May 1998;25(2):199-209. [Medline].

  16. Frauscher F, Janetschek G, Helweg G. Crossing vessels at the ureteropelvic junction: detection with contrast- enhanced color Doppler imaging. Radiology. Mar 1999;210(3):727-31. [Medline].

  17. Jabbour ME, Goldfischer ER, Klima WJ. Endopyelotomy after failed pyeloplasty: the long-term results. J Urol. Sep 1998;160(3 Pt 1):690-2; discussion 692-3. [Medline].

  18. Johnston JH, Evans JP, Glassberg KI. Pelvic hydronephrosis in children: a review of 219 personal cases. J Urol. Jan 1977;117(1):97-101. [Medline].

  19. Kumar R, Kapoor R, Mandhani A. Optimum duration of splinting after endopyelotomy. J Endourol. Mar 1999;13(2):89-92. [Medline].

  20. Lee RS, Retik AB, Borer JG, Peters CA. Pediatric robot assisted laparoscopic dismembered pyeloplasty: comparison with a cohort of open surgery. J Urol. Feb 2006;175(2):683-7; discussion 687. [Medline].

  21. Lopez-Pujals A, Leveillee RJ, Wong C. Application of strict radiologic criteria to define success in laparoscopic pyeloplasty. J Endourol. Oct 2004;18(8):756-60. [Medline].

  22. Matlaga BR, Shah OD, Singh D, Streem SB, Assimos DG. Ureterocalicostomy: a contemporary experience. Urology. Jan 2005;65(1):42-4. [Medline].

  23. McDaniel BB, Jones RA, Scherz H, Kirsch AJ, Little SB, Grattan-Smith JD. Dynamic contrast-enhanced MR urography in the evaluation of pediatric hydronephrosis: Part 2, anatomic and functional assessment of uteropelvic junction obstruction. AJR Am J Roentgenol. Dec 2005;185(6):1608-14. [Medline].

  24. Mitterberger M, Pinggera GM, Neururer R, Peschel R, Colleselli D, Aigner F, et al. Comparison of contrast-enhanced color Doppler imaging (CDI), computed tomography (CT), and magnetic resonance imaging (MRI) for the detection of crossing vessels in patients with ureteropelvic junction obstruction (UPJO). Eur Urol. Jun 2008;53(6):1254-60. [Medline].

  25. Murakumo M, Nonomura K, Yamashita T, Ushiki T, Abe K, Koyanagi T. Structural changes of collagen components and diminution of nerves in congenital ureteropelvic junction obstruction. J Urol. May 1997;157(5):1963-8. [Medline].

  26. Niemczyk P, Krisch EB, Zeiger L. Use of diuretic renogram in evaluation of patients before and after endopyelotomy. Urology. Feb 1999;53(2):271-5. [Medline].

  27. Park JM, Bloom DA. The pathophysiology of UPJ obstruction. Current concepts. Urol Clin North Am. May 1998;25(2):161-9. [Medline].

  28. Patel V. Robotic-assisted laparoscopic dismembered pyeloplasty. Urology. Jul 2005;66(1):45-9. [Medline].

  29. Reddy PP, Mandell J. Prenatal diagnosis. Therapeutic implications. Urol Clin North Am. May 1998;25(2):171-80. [Medline].

  30. Richstone L, Seideman CA, Reggio E, Bluebond-Langner R, Pinto PA, Trock B, et al. Pathologic Findings in Patients With Ureteropelvic Junction Obstruction and Crossing Vessels. Urology. Feb 2 2009;[Medline].

  31. Rooks VJ, Lebowitz RL. Extrinsic ureteropelvic junction obstruction from a crossing renal vessel: demography and imaging. Pediatr Radiol. Feb 2001;31(2):120-4. [Medline].

  32. Shalhav AL, Giusti G, Elbahnasy AM. Adult endopyelotomy: impact of etiology and antegrade versus retrograde approach on outcome. J Urol. Sep 1998;160(3 Pt 1):685-9. [Medline].

  33. Siddiq FM, Leveillee RJ, Villicana P, Bird VG. Computer-assisted laparoscopic pyeloplasty: University of Miami experience with the daVinci Surgical System. J Endourol. Apr 2005;19(3):387-92. [Medline].

  34. Smith AD, Horgan JD. Endopyelotomy and Pyeloplasty. In: Clinical Urology. Philadelphia, Pa: JB Lippincott; 1994:433-43.

  35. Thomas DF. Fetal uropathy. Br J Urol. Sep 1990;66(3):225-31. [Medline].

  36. Wang Y, Puri P, Hassan J, Miyakita H, Reen DJ. Abnormal innervation and altered nerve growth factor messenger ribonucleic acid expression in ureteropelvic junction obstruction. J Urol. Aug 1995;154(2 Pt 2):679-83. [Medline].

  37. Yurkanin JP, Fuchs GJ. Laparoscopic dismembered pyeloureteroplasty: a single institution's 3-year experience. J Endourol. Oct 2004;18(8):765-9. [Medline].

Further Reading

Keywords

ureteropelvic junction obstruction, UPJ obstruction, UPJO, hydronephrosis, antenatal hydronephrosis, neonatal hydronephrosis, obstructed ureteropelvic junction, obstructed UPJ, urosepsis, ureteral hypoplasia, ureteral entrapment, crossing lower pole renal vessels, renal ectopy, renal hypermobility, endopyelotomy, ureterocalicostomy, pyeloplasty, laparoscopic pyeloplasty, congenital ureteropelvic junction obstruction, secondary ureteropelvic junction obstruction, primary ureteropelvic junction obstruction, intrinsic ureteropelvic junction obstruction, congenital UPJO, secondary UPJO, primary UPJO, intrinsic UPJO

Contributor Information and Disclosures

Author

Michael Grasso, MD, Chairman, Department of Urology, Saint Vincent's Medical Center; Professor and Vice Chairman, Department of Urology, New York Medical College
Michael Grasso, MD is a member of the following medical societies: American Medical Association, American Urological Association, California Medical Association, and Endourological Society
Disclosure: Karl Storz Endoscopy Consulting fee Consulting; Boston Scientific Consulting fee Consulting

Coauthor(s)

Srinivas Rajamahanty, MD, MCh, Staff Physician, Department of Urology, Westchester Medical Center, Valhalla, New York
Disclosure: Nothing to disclose.

Jordan S Gitlin, MD, Assistant Professor, Department of Urology, Albert Einstein College of Medicine-Yeshiva University; Consulting Staff, Pediatric Urology Associates PC
Jordan S Gitlin, MD is a member of the following medical societies: Alpha Omega Alpha and American Urological Association
Disclosure: Nothing to disclose.

G Blake Johnson, MD, Consulting Staff, Middleton Urology Associates
G Blake Johnson, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, and American Urological Association
Disclosure: Nothing to disclose.

Medical Editor

Allen Donald Seftel, MD, Professor, Department of Urology, Case School of Medicine
Allen Donald Seftel, MD is a member of the following medical societies: Ohio State Medical Association
Disclosure: lilly Consulting fee Consulting; sanofi-aventis Consulting fee Consulting; auxilium Consulting fee Consulting; solvay Consulting fee Consulting; plethora Grant/research funds clinical trial; indevus Consulting fee Consulting; nature publishing  journal editor

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Shlomo Raz, MD, Professor, Department of Surgery, Division of Urology, University of California at Los Angeles School of Medicine
Shlomo Raz, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, and California Medical Association
Disclosure: Nothing to disclose.

CME Editor

J Stuart Wolf Jr, MD, FACS, David A Bloom Professor of Urology, Director of Division of Minimally Invasive Urology, Department of Urology, University of Michigan
J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology
Disclosure: Terumo Corporation Consulting fee Consulting; Omeros Corporation Consulting fee Consulting

Chief Editor

Bradley Fields Schwartz, DO, FACS, Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine
Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.